Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP-sensitive inward rectifier potassium channel 11, also known as Kir6.2, is a protein encoded by the KCNJ11 gene. It forms the pore-forming subunit of ATP-sensitive potassium (KATP) channels, which are crucial for linking cellular metabolism to electrical activity in various tissues, most notably pancreatic beta cells and cardiac muscle. The functional KATP channel is a hetero-octameric complex composed of four Kir6.2 subunits forming the central pore and four regulatory sulfonylurea receptor subunits (SUR1/ABCC8 or SUR2/ABCC9). The activity of this channel is regulated by intracellular nucleotides: ATP inhibits, and ADP activates. Mutations in KCNJ11 are associated with neonatal and type II diabetes mellitus. Channel activity can be modulated pharmacologically, making it an important drug target for diabetes management.
Sulfonylureas inhibit the channel, while certain openers activate it.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-sensitive Inward Rectifier Potassium Channel 11 (Kir6.2).